TXLNGY
Putative gamma-taxilin 2
Also known as: TXNG2_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for TXLNGY in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
131 residues, UniProt reviewed canonical sequence.
>Q9BZA5|TXLNGY
1 MEEAGLCGLR EKADMLCNSE SHDILQHQDS NCSATSNKHL LEDEEGRDFI TKNRSWVSPV
61 HCTQESRREL PEQEVAPPSG QQALQCNRNK EKVLGKEVLL LMQALNTLST PEEKLAALCK
121 KYADLGNSPL LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TXLNGY can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
OntologyGO
Molecular functions
Protein domainsUniProt · Pfam · InterPro
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TXLNGY as an antibody target. Whether an autoantibody or antibody against TXLNGY could matter depends on whether native TXLNGY is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TXLNGY is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TXLNGY as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...